ATE88633T1 - Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. - Google Patents
Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.Info
- Publication number
- ATE88633T1 ATE88633T1 AT88201733T AT88201733T ATE88633T1 AT E88633 T1 ATE88633 T1 AT E88633T1 AT 88201733 T AT88201733 T AT 88201733T AT 88201733 T AT88201733 T AT 88201733T AT E88633 T1 ATE88633 T1 AT E88633T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium citrate
- citrate malate
- osteoporosis
- treatment
- malate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9100687A | 1987-08-28 | 1987-08-28 | |
EP88201733A EP0304986B1 (de) | 1987-08-28 | 1988-08-15 | Verwendung von bestimmten Calcium-Citrate-Malaten zur Herstellung einer pharmazeutischen Zubereitung für die Behandlung von Osteoporose. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE88633T1 true ATE88633T1 (de) | 1993-05-15 |
Family
ID=22225323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88201733T ATE88633T1 (de) | 1987-08-28 | 1988-08-15 | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0304986B1 (de) |
JP (1) | JP2738541B2 (de) |
KR (1) | KR970009582B1 (de) |
AT (1) | ATE88633T1 (de) |
CA (1) | CA1329774C (de) |
DE (1) | DE3880587T2 (de) |
HK (1) | HK94096A (de) |
IE (1) | IE61451B1 (de) |
PH (1) | PH25585A (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108761A (en) * | 1990-10-01 | 1992-04-28 | The Procter & Gamble Company | Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium |
JPH06502310A (ja) * | 1990-10-31 | 1994-03-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | カルシウム強化ソース |
US5389387A (en) * | 1991-12-26 | 1995-02-14 | The Procter & Gamble Company | Storage stable calcium-supplemented beverage concentrates |
AU3240193A (en) * | 1991-12-26 | 1993-07-28 | Procter & Gamble Company, The | Storage stable calcium-supplemented beverage concentrates |
AU4597293A (en) * | 1992-06-30 | 1994-01-24 | Procter & Gamble Company, The | Effervescent calcium supplements |
EP0665720B1 (de) * | 1992-10-21 | 1996-07-10 | The Procter & Gamble Company | Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup |
CA2146632C (en) * | 1992-10-21 | 1999-02-23 | Alice Lyles Burkes | Sweetener containing a concentrated bioavailable calcium source |
JP3199742B2 (ja) * | 1992-10-21 | 2001-08-20 | ザ、プロクター、エンド、ギャンブル、カンパニー | 濃縮された生物学的利用性カルシウム源 |
IT1256300B (it) * | 1992-11-05 | 1995-11-29 | Dompe Farmaceutici Spa | Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici |
JP2002525091A (ja) * | 1998-09-29 | 2002-08-13 | ザ プロクター アンド ギャンブル カンパニー | 栄養性カルシウム源が補給された低酸性飲料 |
US6811800B2 (en) | 1998-09-29 | 2004-11-02 | The Procter & Gamble Co. | Calcium fortified beverages |
AU2007285386B2 (en) * | 2006-08-17 | 2011-02-03 | The Procter & Gamble Company | Compositions comprising calcium citrate malate and methods for making the same |
TR200908237A2 (tr) | 2009-11-02 | 2011-05-23 | Bi̇lgi̇ç Mahmut | Kalsiyum ve D vitamini içeren farmasötik bileşimler. |
WO2012125524A1 (en) * | 2011-03-16 | 2012-09-20 | The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center | Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5697248A (en) * | 1979-12-28 | 1981-08-05 | Tanaka Shiro | Conjugated compound of calcium citrate and calcium malate and its preparation |
FR2601249A1 (fr) * | 1986-07-09 | 1988-01-15 | Sandoz Lab | Nouvelles compositions pharmaceutiques a base de sels de calcium. |
US4786510A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
-
1988
- 1988-08-15 EP EP88201733A patent/EP0304986B1/de not_active Expired - Lifetime
- 1988-08-15 AT AT88201733T patent/ATE88633T1/de not_active IP Right Cessation
- 1988-08-15 DE DE8888201733T patent/DE3880587T2/de not_active Expired - Lifetime
- 1988-08-25 CA CA000575678A patent/CA1329774C/en not_active Expired - Lifetime
- 1988-08-26 PH PH37460A patent/PH25585A/en unknown
- 1988-08-26 IE IE260988A patent/IE61451B1/en not_active IP Right Cessation
- 1988-08-26 KR KR88010858A patent/KR970009582B1/ko not_active IP Right Cessation
- 1988-08-27 JP JP63213488A patent/JP2738541B2/ja not_active Expired - Lifetime
-
1996
- 1996-05-30 HK HK94096A patent/HK94096A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2738541B2 (ja) | 1998-04-08 |
DE3880587D1 (de) | 1993-06-03 |
KR890003390A (ko) | 1989-04-14 |
IE61451B1 (en) | 1994-11-02 |
IE882609L (en) | 1989-02-28 |
HK94096A (en) | 1996-06-07 |
KR970009582B1 (en) | 1997-06-14 |
DE3880587T2 (de) | 1993-09-23 |
JPH01151515A (ja) | 1989-06-14 |
PH25585A (en) | 1991-08-08 |
CA1329774C (en) | 1994-05-24 |
EP0304986A2 (de) | 1989-03-01 |
EP0304986B1 (de) | 1993-04-28 |
EP0304986A3 (en) | 1990-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
DE69016755D1 (de) | Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen. | |
ATE88633T1 (de) | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. | |
DE3774449D1 (de) | Pharmazeutische zusammensetzungen. | |
ATE130762T1 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
ATE71629T1 (de) | Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels. | |
DE69634357D1 (de) | Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten | |
ATE133859T1 (de) | Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen | |
DE3685853D1 (de) | Mittel zur behandlung von knochenkrankheiten. | |
ATE82120T1 (de) | Kalziumzusaetze. | |
DE69420776D1 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
HU896916D0 (en) | Process for producing medical preparation for treating toxoplasmosis | |
DE3879489D1 (de) | Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. | |
DE68916443D1 (de) | Arzneimittel zur behandlung von kryptosporidiose. | |
DE68901018D1 (de) | Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet. | |
DE3776662D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit. | |
PT95867A (pt) | Processo para a preparacao de uma composicao de libertacao retardada compreendendo um copolimero de lactide e glicolide, para tratamento de doencas periodonticas | |
DE3887005D1 (de) | Mittel zur Behandlung von Nierenbeschwerden. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |